Zeng Lab
Home
About
Professor Zeng Qi
Lab Members
Research
Publications
News
Contact
Gallery
More
14 Jul 2025
Singapore-Developed Cancer Drug Shows Promise As Treatment For Blindness
Locally Developed Cancer Drug Shows Promise As Treatment for Blindness; Trial To Start Soon
本地抗癌药 新用途 有望治疗两大致盲疾病 (Locally developed anti-cancer drug finds new application, potentially treating two major blinding diseases)
Singapore-Developed Cancer Drug Shows Promise as Treatment for Blindness
27 May 2025
Phase II Trial Completed – Singapore’s New Anti-Cancer Drug One Step Away from Market
完成二期试验 本地抗癌新药离面市仅一步 (After Completing The Phase II Clinical Trial, The Local New Anti-Cancer Drug Is Only One Step Away From Being Launched On The Market)
09 May 2025
SINGAPORE-DEVELOPED CANCER IMMUNOTHERAPY OFFERS NEW HOPE FOR LATE-STAGE CANCER PATIENTS PRL3-zumab demonstrates safety and clinical benefit in FDA-approved Phase II trial across multiple cancer types
Intra-ImmuSG Focuses on Intracellular Targets for Cancer Immunotherapy
16 Jan 2025
Unlocking New Therapeutic Pathways: PRL1 and PRL3 in Tumour Growth and Cancer Immunotherapy
04 Mar 2024
Targeted Therapy Sparks Childhood Cancer Hope
_PNG.jpg)
.png)
